QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Hill-RomGlobus MedicalHaemoneticsiRhythm TechnologiesNevro
SymbolNYSE:HRCNYSE:GMEDNYSE:HAENASDAQ:IRTCNYSE:NVRO
Price Information
Current Price$100.55$60.46$119.59$143.16$155.70
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score2.21.61.61.61.4
Analysis Score2.42.42.54.33.4
Community Score2.52.82.22.93.0
Dividend Score1.70.00.00.00.0
Ownership Score1.70.81.70.00.0
Earnings & Valuation Score2.51.91.90.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$121.00$66.40$144.80$212.67$181.38
% Upside from Price Target20.34% upside9.82% upside21.08% upside48.55% upside16.50% upside
Trade Information
Market Cap$6.67 billion$6.03 billion$6.08 billion$4.17 billion$5.39 billion
Beta0.581.020.561.681.02
Average Volume459,586485,656388,967678,667439,796
Sales & Book Value
Annual Revenue$2.88 billion$785.37 million$988.48 million$214.55 million$390.26 million
Price / Sales2.327.686.1519.4613.81
Cashflow$10.13 per share$2.06 per share$5.29 per shareN/AN/A
Price / Cash9.9329.4122.59N/AN/A
Book Value$25.92 per share$14.05 per share$11.67 per share$5.09 per share$6.98 per share
Price / Book3.884.3010.2528.1322.31
Profitability
Net Income$223 million$155.21 million$76.53 million$-54,570,000.00$-103,690,000.00
EPS$5.53$1.68$3.31($2.16)($3.37)
Trailing P/E Ratio30.2965.7257.77N/AN/A
Forward P/E Ratio16.3529.6434.07N/AN/A
P/E Growth3.002.895.17N/AN/A
Net Margins7.74%12.36%11.76%-20.97%-24.46%
Return on Equity (ROE)22.71%9.85%22.85%-28.89%-30.25%
Return on Assets (ROA)8.01%9.04%10.40%-15.11%-14.57%
Dividend
Annual Payout$0.88N/AN/AN/AN/A
Dividend Yield0.88%N/AN/AN/AN/A
Three-Year Dividend Growth22.22%N/AN/AN/AN/A
Payout Ratio15.91%N/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.96%N/A0.44%0.07%0.37%
Current Ratio1.43%8.12%2.25%6.55%3.10%
Quick Ratio1.06%5.80%1.34%6.46%2.75%
Ownership Information
Institutional Ownership Percentage83.75%64.35%96.22%N/AN/A
Insider Ownership Percentage0.65%25.63%1.63%3.10%7.60%
Miscellaneous
Employees10,0002,0003,004997853
Shares Outstanding66.36 million99.80 million50.82 million29.16 million34.62 million
Next Earnings Date5/7/2021 (Estimated)5/6/2021 (Estimated)5/4/2021 (Estimated)5/6/2021 (Estimated)5/4/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.